Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.2B | 10.5B | 11.5B | 15.8B |
Cost of revenue | 5.8B | 8.1B | 6.0B | 8.5B |
Gross profit | 6.4B | 2.4B | 5.5B | 7.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 6.7B | -4.9B | 6.8B | 10.7B |
Other operating expenses | — | — | — | — |
Operating income | 6.4B | -2.1B | -1.3B | -3.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | -5.4B | -8.2B | 2.2B | -13.2B |
Tax provision | 35.5M | -1.9B | 192.9M | -2.5B |
Net income | -5.4B | -6.3B | 2.0B | -10.8B |
Basic EPS | -477.3 | — | 177 | -952 |
Diluted EPS | -477.3 | — | 177 | -952 |
Basic average shares | — | — | 11.3M | 11.3M |
Diluted average shares | — | — | 11.3M | 11.3M |
EBITDA | 6.4B | -10.3B | -930.4M | -3.1B |
Net income from continuing op. | — | -6.3B | 2.0B | -10.8B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |